Vice President, Business Development and Licensing
RecursionNew York City, New York, United States · Posted 3 days agoDescription
Your work will change lives. Including your own.
The Impact You’ll Make
Recursion is at the forefront of reimagining drug discovery. We are building an AI-native platform spanning biology, chemistry, and clinical development; we've signed validating collaborations with partners across biopharma and tech; and we've built a robust internal pipeline with multiple clinical trials underway.
You will lead business development and licensing activities pertaining to our portfolio of first-in-class and best-in-class molecules. You will work closely with our internal asset leadership teams to identify licensing and co-development opportunities, conduct rigorous technical and commercial due diligence, structure and negotiate high-impact transactions that drive value and validate our underlying platform technology. You'll interact daily with colleagues across Biology, Chemistry, Clinical Development, Safety, CMC, Data Science, Legal, and Finance to drive alignment and deliver with speed.
In this role, you will:
- Initiate and build enduring relationships with senior business development and licensing counterparts at pharma and biotech organizations
- Identify value-maximizing development and commercialization partners for Recursion’s existing clinical and preclinical assets
- Partner with search and evaluation teams and cross-functional department leads to identify, prioritize, and diligence in-licensing and asset acquisition opportunities in Recursion’s key therapeutic areas (oncology, I&I)
- Structure, negotiate, and execute a diverse array of agreements (licensing, acquisition, co-development/co-commercialization, spin-out) that align with Recursion's strategic objectives and values
- Consolidate industry-wide feedback and advise internal teams on critical data-package deliverables
- Represent Recursion's platform and acquisition strategy to senior scientific and business leaders across the industry
The Team You'll Join
You will be an essential member of Recursion's Corporate Development team, reporting to our Chief Business Officer. The team is an empowered, execution-minded group of business development and alliance management professionals responsible for building Recursion's clinical- and preclinical-stage portfolio through strategic acquisitions, licensing deals, and partnerships. You will work seamlessly with our asset leadership team that focuses on market intelligence, screening, and technical assessment of potential targets. In this collaborative environment, you will need self-initiative, a collaborative mindset, and the ability to communicate with colleagues at all levels.
The Experience You'll Need
- BS/BA in life sciences (biology, chemistry, pharmacy, medical)
- Advanced degree (JD, MBA, PhD, PharmD) strongly preferred
- 12-15+ years of experience in the biotechnology or pharmaceutical industry, with a focus on oncology and I&I
- 7+ years of direct business development and licensing experience with a strong track record of success in both buy-side and sell-side transactions
- Strong network of senior relationships across biotechnology and large pharma
- Deep knowledge of the drug development process from early discovery through clinical development and commercialization
- Track record of leading complex, multi-stakeholder negotiations and closing high-value transactions
- Demonstrated ability to manage multiple complex projects efficiently with a high degree of independence
- Exceptional cross-functional collaboration skills and ability to communicate complex technical and commercial concepts to diverse audiences
- Demonstrated interest in AI-enabled drug discovery space
Working Location & Compensation:
This is an office-based role in our New York City office, with flexibility to work remotely as needed. Travel to conferences and partnering events is expected every 4-6 weeks.
At Recursion, we believe that every employee should be compensated fairly. Based on the skills, experience, and qualifications needed for this role, the estimated annual base salary range is: $336,380–$404,140. In addition to base salary, this role is eligible for an annual bonus, equity compensation, and a comprehensive benefits package.
#LI-DB1
The Values We Hope You Share:
- We act boldly with integrity. We are unconstrained in our thinking, take calculated risks, and push boundaries, but never at the expense of ethics, science, or trust.
- We care deeply and engage directly. Caring means holding a deep sense of responsibility and respect - showing up, speaking honestly, and taking action.
- We learn actively and adapt rapidly. Progress comes from doing. We experiment, test, and refine, embracing iteration over perfection.
- We move with urgency because patients are waiting. Speed isn’t about rushing but about moving the needle every day.
- We take ownership and accountability. Through ownership and accountability, we enable trust and autonomy—leaders take accountability for decisive action, and teams own outcomes together.
- We are One Recursion. True cross-functional collaboration is about trust, clarity, humility, and impact. Through sharing, we can be greater than the sum of our individual capabilities.
Our values underpin the employee experience at Recursion. They are the character and personality of the company demonstrated through how we communicate, support one another, spend our time, make decisions, and celebrate collectively.
More About Recursion
Recursion (NASDAQ: RXRX) is a clinical-stage TechBio company decoding biology to radically improve lives. Recursion is advancing a portfolio of differentiated investigational medicines across its wholly owned and partnered pipeline in oncology, rare disease, neuroscience, immunology, and other therapeutic areas with significant unmet need. Enabling its mission is the Recursion OS, an AI-native, end-to-end drug discovery and development platform integrating biology, chemistry, and clinical development into a unified intelligence system. Powered by proprietary multimodal data, purpose-built AI models, and bilingual teams fluent in both science and AI, the Recursion OS is designed to translate complex science into medicines that matter — faster, better, and at scale — for patients who are waiting.
Recursion’s platform infrastructure is anchored in Salt Lake City, Utah and Milton Park, Oxfordshire, where its automated biology and chemistry laboratories generate proprietary data at industrial scale. Recursion also maintains offices in New York, Montréal, and London, three global hubs for talent and leadership at the intersection of AI and scientific innovation. Learn more at www.recursion.com, or connect on X and LinkedIn.
Recursion is an Equal Opportunity Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, age, disability, veteran status, or any other characteristic protected under applicable federal, state, local, or provincial human rights legislation.
Accommodations are available on request for candidates taking part in all aspects of the selection process.
Recursion leverages AI in our hiring process. We use Greenhouse's Talent Matching AI technology feature to help review applications against the skills and experience we've identified as important for this role. It analyzes your resume and application responses to assess how closely your qualifications match our criteria - but all decisions are made by our human recruiters and hiring managers, including whether to move to the next phase of review. Talent Matching does not automatically advance or reject any candidate. By submitting your application, you acknowledge that you have been informed about and consent to this use of the Talent Matching tool in our review process. Please refer to our Recursion Privacy Policy at https://www.recursion.com/privacy-notice/ for more information about our processing of personal data and your rights.
Recruitment & Staffing Agencies: Recursion Pharmaceuticals and its affiliate companies do not accept resumes from any source other than candidates. The submission of resumes by recruitment or staffing agencies to Recursion or its employees is strictly prohibited unless contacted directly by Recursion’s internal Talent Acquisition team. Any resume submitted by an agency in the absence of a signed agreement will automatically become the property of Recursion, and Recursion will not owe any referral or other fees. Our team will communicate directly with candidates who are not represented by an agent or intermediary unless otherwise agreed to prior to interviewing for the job.
Similar jobs
Est. 210,250 USD
Your work will change lives. Including your own. The Impact You’ll Make As an Associate Director within Recursion’s early discovery team, you will be at the forefront of reimagining drug discovery from first principles.…
Est. 176,200 USD
Your work will change lives. Including your own. The Impact You’ll Make As a Manager within Recursion's partnership-facing data science team, you will be at the forefront of reimagining drug discovery from first principl…
Est. 193,820 USD
Your work will change lives. Including your own. The Impact You’ll Make As a computational biologist within Recursion’s early discovery team, you will be at the forefront of reimagining drug discovery from first principl…
Est. 193,820 USD
Your work will change lives. Including your own. The Impact You’ll Make As a computational biologist within Recursion’s early discovery team, you will be at the forefront of reimagining drug discovery from first principl…
Est. 260,000 USD
Your work will change lives. Including your own. The Impact You’ll Make You will join an innovative and passionate clinical development team dedicated to improving the lives of patients suffering from devastating disease…
Est. 254,485 USD
Your work will change lives. Including your own. The Impact You’ll Make Recursion is at the forefront of reimagining drug discovery and development through broadening the funnel of potential targets, using technology and…
Est. 127,400 GBP
Your work will change lives. Including your own. The Impact You’ll Make You will join an innovative and passionate clinical development team dedicated to improving the lives of patients suffering from devastating disease…
Est. 326,700 USD
Your work will change lives. Including your own. The Impact You’ll Make As the Recursion clinical asset pipeline continues to mature through key inflection points, the advancing assets require leaders who can translate s…
Est. 126,450 GBP
Your work will change lives. Including your own. The Impact You’ll Make Recursion is at the forefront of reimagining drug discovery and development through broadening the funnel of potential targets, using technology and…
Est. 80,000 USD
Your work will change lives. Including your own. Join our Talent Network! We believe in the power of hiring because the potential for people to do outstanding work depends on being in the right role, on the right team, a…
Your work will change lives. Including your own. The Impact You’ll Make You will lead a team working to build, scale, and optimize the machine learning infrastructure that powers Recursion's drug discovery platform. From…
Est. 60,000 USD
Your work will change lives. Including your own. Join our Internship Talent Network! We believe in the power of hiring because the potential for people to do outstanding work depends on being in the right role, on the ri…
Est. 237,500 USD
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress…
Est. 330,500 USD
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress…
Est. 298,000 USD
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress…
Est. 216,050 USD
About Acadia Pharmaceuticals Acadia is committed to turning scientific promise into meaningful innovation that makes the difference for underserved neurological and rare disease communities around the world. Our commerci…
Est. 214,000 USD
What if you could join a rapidly growing company and play a critical role in bringing new medicines to patients through looking at and treating disease in a revolutionary way. What this position is all about: What if you…
Est. 261,000 USD
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress…
Est. 175,800 USD
About Acadia Pharmaceuticals Acadia is committed to turning scientific promise into meaningful innovation that makes the difference for underserved neurological and rare disease communities around the world. Our commerci…
Est. 330,500 USD
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress…
Est. 274,500 USD
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress…
Est. 274,500 USD
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress…
Est. 298,000 USD
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress…
Est. 199,000 USD
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress…
Est. 209,500 USD
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress…
Est. 209,500 USD
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress…
Est. 261,000 USD
Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) t…
Est. 274,500 USD
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress…
Est. 226,000 USD
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress…
Est. 174,100 USD
About Acadia Pharmaceuticals Acadia is committed to turning scientific promise into meaningful innovation that makes the difference for underserved neurological and rare disease communities around the world. Our commerci…